Plehn-Dujowich, Debora
Eckert Seamans | Member
In This Section
Debora Plehn-Dujowich has extensive experience as a patent attorney focusing on life sciences technologies.
Debora began her career as a molecular biologist having obtained her Ph.D. from Yale University. Following postdoctoral studies and some time as an academic professor, Debora made the switch to patent law. She focuses her patent law practice on the biomedical sciences and assists clients in identifying, protecting and enforcing their intellectual property in the life sciences space.
Debora's experience includes: conducting patent preparation and prosecution; conducting due diligence; drafting licensing agreements; and preparing patentability opinions, landscape opinions and freedom to operate opinions. Debora has also conducted reexamination and interference proceedings.
Debora focuses in particular on IP matters including but not limited to the areas of biotechnology, biochemistry, tissue culture, vaccines, oncology, virology, immunotherapy, immunology, antibodies, microbiome, plants, seeds, agriculture, food chemistry, consumer products, medical devices, protein chemistry, organic chemistry, small molecules, material science, nanotechnology, electronics, polymers, natural products, chemical processes, water treatment, environment, pharmaceuticals and diagnostics.
Debora began her career as a molecular biologist having obtained her Ph.D. from Yale University. Following postdoctoral studies and some time as an academic professor, Debora made the switch to patent law. She focuses her patent law practice on the biomedical sciences and assists clients in identifying, protecting and enforcing their intellectual property in the life sciences space.
Debora's experience includes: conducting patent preparation and prosecution; conducting due diligence; drafting licensing agreements; and preparing patentability opinions, landscape opinions and freedom to operate opinions. Debora has also conducted reexamination and interference proceedings.
Debora focuses in particular on IP matters including but not limited to the areas of biotechnology, biochemistry, tissue culture, vaccines, oncology, virology, immunotherapy, immunology, antibodies, microbiome, plants, seeds, agriculture, food chemistry, consumer products, medical devices, protein chemistry, organic chemistry, small molecules, material science, nanotechnology, electronics, polymers, natural products, chemical processes, water treatment, environment, pharmaceuticals and diagnostics.